We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Recommends Additional MR Exam for Fetal Brain Abnormalities

By HospiMedica International staff writers
Posted on 20 Dec 2016
Researchers have found that potential brain abnormalities discovered in a routine mid-pregnancy ultrasound scan, can be diagnosed accurately using an additional MRI scan.

The study included 570 pregnant women who had undergone an ultrasound scan between weeks 18 and 21 of their pregnancy that showed a possible brain abnormality in the baby. More...
Nearly 93% of the extra Magnetic Resonance Imaging (MRI) scans that were carried out within two weeks of the initial ultrasound scan were correct, and increased the accuracy of the diagnosis. In the case of pregnant women who underwent only the mid-pregnancy ultrasound scan the accuracy rate was only 68%. In nearly half the cases (49%) the MRI scan provided additional information about the brain abnormality.

The study was published in the December 14, 2016, online issue of the journal Lancet. To confirm the accuracy of the scans, the babies were scanned again after birth. The additional certainty provided by the MRI scan enabled the clinicians to arrive at a more accurate diagnosis, and provide better advice to the parents of the babies.

Lead author of the study, professor Paul Griffiths, the University of Sheffield (Sheffield, UK), said, "This study is the first of its kind and has shown that adding an MRI scan when a problem is detected provides additional information to support parents making decisions about their pregnancy. Based on our findings we propose that an MRI scan should be given in any pregnancy where the foetus may have a suspected brain abnormality."

Related Links:
University of Sheffield


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Resorbable Bovine Collagen Membrane
GenDerm
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.